Copyright Reports & Markets. All rights reserved.

Global Anti-inflammatory Therapeutics Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Anti-inflammatory Therapeutics Revenue
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Anti-inflammatory Biologics
      • 1.4.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
      • 1.4.4 Corticosteroids
      • 1.4.5 Others
    • 1.5 Market by Application
      • 1.5.1 Global Anti-inflammatory Therapeutics Market Share by Application: 2020 VS 2026
      • 1.5.2 Arthritis
      • 1.5.3 Respiratory Diseases
      • 1.5.4 Dermatology
      • 1.5.5 Gastroenterology
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends by Regions

    • 2.1 Anti-inflammatory Therapeutics Market Perspective (2015-2026)
    • 2.2 Anti-inflammatory Therapeutics Growth Trends by Regions
      • 2.2.1 Anti-inflammatory Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Anti-inflammatory Therapeutics Historic Market Share by Regions (2015-2020)
      • 2.2.3 Anti-inflammatory Therapeutics Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Anti-inflammatory Therapeutics Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Anti-inflammatory Therapeutics Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Anti-inflammatory Therapeutics Players by Market Size
      • 3.1.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2015-2020)
      • 3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Anti-inflammatory Therapeutics Market Concentration Ratio
      • 3.2.1 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapeutics Revenue in 2019
    • 3.3 Anti-inflammatory Therapeutics Key Players Head office and Area Served
    • 3.4 Key Players Anti-inflammatory Therapeutics Product Solution and Service
    • 3.5 Date of Enter into Anti-inflammatory Therapeutics Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2015-2026)

    • 4.1 Global Anti-inflammatory Therapeutics Historic Market Size by Type (2015-2020)
    • 4.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2021-2026)

    5 Anti-inflammatory Therapeutics Breakdown Data by Application (2015-2026)

    • 5.1 Global Anti-inflammatory Therapeutics Market Size by Application (2015-2020)
    • 5.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Anti-inflammatory Therapeutics Market Size (2015-2020)
    • 6.2 Anti-inflammatory Therapeutics Key Players in North America (2019-2020)
    • 6.3 North America Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
    • 6.4 North America Anti-inflammatory Therapeutics Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Anti-inflammatory Therapeutics Market Size (2015-2020)
    • 7.2 Anti-inflammatory Therapeutics Key Players in Europe (2019-2020)
    • 7.3 Europe Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
    • 7.4 Europe Anti-inflammatory Therapeutics Market Size by Application (2015-2020)

    8 China

    • 8.1 China Anti-inflammatory Therapeutics Market Size (2015-2020)
    • 8.2 Anti-inflammatory Therapeutics Key Players in China (2019-2020)
    • 8.3 China Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
    • 8.4 China Anti-inflammatory Therapeutics Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Anti-inflammatory Therapeutics Market Size (2015-2020)
    • 9.2 Anti-inflammatory Therapeutics Key Players in Japan (2019-2020)
    • 9.3 Japan Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
    • 9.4 Japan Anti-inflammatory Therapeutics Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Anti-inflammatory Therapeutics Market Size (2015-2020)
    • 10.2 Anti-inflammatory Therapeutics Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Anti-inflammatory Therapeutics Market Size by Application (2015-2020)

    11 India

    • 11.1 India Anti-inflammatory Therapeutics Market Size (2015-2020)
    • 11.2 Anti-inflammatory Therapeutics Key Players in India (2019-2020)
    • 11.3 India Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
    • 11.4 India Anti-inflammatory Therapeutics Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Anti-inflammatory Therapeutics Market Size (2015-2020)
    • 12.2 Anti-inflammatory Therapeutics Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
    • 12.4 Central & South America Anti-inflammatory Therapeutics Market Size by Application (2015-2020)

    13Key Players Profiles

    • 13.1 AbbVie
      • 13.1.1 AbbVie Company Details
      • 13.1.2 AbbVie Business Overview and Its Total Revenue
      • 13.1.3 AbbVie Anti-inflammatory Therapeutics Introduction
      • 13.1.4 AbbVie Revenue in Anti-inflammatory Therapeutics Business (2015-2020))
      • 13.1.5 AbbVie Recent Development
    • 13.2 Johnson & Johnson
      • 13.2.1 Johnson & Johnson Company Details
      • 13.2.2 Johnson & Johnson Business Overview and Its Total Revenue
      • 13.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Introduction
      • 13.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
      • 13.2.5 Johnson & Johnson Recent Development
    • 13.3 Amgen Inc
      • 13.3.1 Amgen Inc Company Details
      • 13.3.2 Amgen Inc Business Overview and Its Total Revenue
      • 13.3.3 Amgen Inc Anti-inflammatory Therapeutics Introduction
      • 13.3.4 Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
      • 13.3.5 Amgen Inc Recent Development
    • 13.4 AstraZeneca PLC
      • 13.4.1 AstraZeneca PLC Company Details
      • 13.4.2 AstraZeneca PLC Business Overview and Its Total Revenue
      • 13.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Introduction
      • 13.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
      • 13.4.5 AstraZeneca PLC Recent Development
    • 13.5 Pfizer, Inc
      • 13.5.1 Pfizer, Inc Company Details
      • 13.5.2 Pfizer, Inc Business Overview and Its Total Revenue
      • 13.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Introduction
      • 13.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
      • 13.5.5 Pfizer, Inc Recent Development
    • 13.6 Novartis
      • 13.6.1 Novartis Company Details
      • 13.6.2 Novartis Business Overview and Its Total Revenue
      • 13.6.3 Novartis Anti-inflammatory Therapeutics Introduction
      • 13.6.4 Novartis Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
      • 13.6.5 Novartis Recent Development
    • 13.7 Roche
      • 13.7.1 Roche Company Details
      • 13.7.2 Roche Business Overview and Its Total Revenue
      • 13.7.3 Roche Anti-inflammatory Therapeutics Introduction
      • 13.7.4 Roche Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
      • 13.7.5 Roche Recent Development
    • 13.8 Merck
      • 13.8.1 Merck Company Details
      • 13.8.2 Merck Business Overview and Its Total Revenue
      • 13.8.3 Merck Anti-inflammatory Therapeutics Introduction
      • 13.8.4 Merck Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
      • 13.8.5 Merck Recent Development
    • 13.9 Sanofi
      • 13.9.1 Sanofi Company Details
      • 13.9.2 Sanofi Business Overview and Its Total Revenue
      • 13.9.3 Sanofi Anti-inflammatory Therapeutics Introduction
      • 13.9.4 Sanofi Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
      • 13.9.5 Sanofi Recent Development
    • 13.10 GlaxoSmithKline
      • 13.10.1 GlaxoSmithKline Company Details
      • 13.10.2 GlaxoSmithKline Business Overview and Its Total Revenue
      • 13.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Introduction
      • 13.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
      • 13.10.5 GlaxoSmithKline Recent Development
    • 13.11 Sun Pharmaceutical Industries Ltd
      • 10.11.1 Sun Pharmaceutical Industries Ltd Company Details
      • 10.11.2 Sun Pharmaceutical Industries Ltd Business Overview and Its Total Revenue
      • 10.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Introduction
      • 10.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
      • 10.11.5 Sun Pharmaceutical Industries Ltd Recent Development
    • 13.12 TEVA
      • 10.12.1 TEVA Company Details
      • 10.12.2 TEVA Business Overview and Its Total Revenue
      • 10.12.3 TEVA Anti-inflammatory Therapeutics Introduction
      • 10.12.4 TEVA Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
      • 10.12.5 TEVA Recent Development

    14Analyst's Viewpoints/Conclusions

      15Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      This report focuses on the global Anti-inflammatory Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-inflammatory Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      AbbVie
      Johnson & Johnson
      Amgen Inc
      AstraZeneca PLC
      Pfizer, Inc
      Novartis
      Roche
      Merck
      Sanofi
      GlaxoSmithKline
      Sun Pharmaceutical Industries Ltd
      TEVA

      Market segment by Type, the product can be split into
      Anti-inflammatory Biologics
      Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
      Corticosteroids
      Others
      On the basis of product type, anti-inflammatory biologics segment is projected to account for the largest revenue share during the forecast period; this segment was estimated to account for 58.35% revenue share in 2019, at a cagr of 6.54% in the forecast period.
      Market segment by Application, split into
      Arthritis
      Respiratory Diseases
      Dermatology
      Gastroenterology
      Others
      Arthritis accounted for over 42.41% global revenue share in 2019. And it is also show a fast growth rate of 6.60% in the next few years from 2020 to 2026.

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Anti-inflammatory Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Anti-inflammatory Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by type, market and key regions.

      In this study, the years considered to estimate the market size of Anti-inflammatory Therapeutics are as follows:
      History Year: 2015-2019
      Base Year: 2019
      Estimated Year: 2020
      Forecast Year 2020 to 2026
      For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now